Application 209500

Type
NDA
Sponsor
INTRA-CELLULAR

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CAPLYTALUMATEPERONE TOSYLATECAPSULE;ORALEQ 42MG BASEYesYes
002CAPLYTALUMATEPERONE TOSYLATECAPSULE;ORALEQ 10.5MG BASEYesNo
003CAPLYTALUMATEPERONE TOSYLATECAPSULE;ORALEQ 21MG BASEYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
70518-3497CAPLYTAlumateperoneREMEDYREPACK INC.NDACurrent
72060-110CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent
72060-110CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent
72060-121CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent
72060-121CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent
72060-142CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent
72060-142CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent
72060-142CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent
72060-142CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent
72060-142CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent
72060-142CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent
72060-142CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent
72060-142CAPLYTAlumateperoneIntra-Cellular Therapies, IncNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85775SUPPL 2026-04-28
85771SUPPL 2026-04-27
84120SUPPL 2025-11-06
84119SUPPL 2025-11-06
84091SUPPL 2025-11-06
74660SUPPL 2023-06-29
74654SUPPL 2023-06-29
70835SUPPL2022-04-27
70834SUPPL2022-04-27
70725SUPPL2022-04-07
70724SUPPL2022-04-07
69719SUPPL2021-12-21
69718SUPPL2021-12-21
69644SUPPL2021-12-19
69643SUPPL2021-12-19
69642SUPPL2021-12-19
61607ORIG2020-01-21
61606ORIG2020-01-21
61400SUPPL2019-12-23
61374SUPPL2019-12-23